UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-QSB

Quarterly Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

For the Quarterly Period Ended:

 

Commission File Number

May 31, 2004

 

1-11038

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)

Delaware

 

41-0857886

(State of Incorporation)

 

(I.R.S. Employer Identification Number)

6680 N. Highway 49, Lino Lakes, MN  55014
(Address of principal executive offices)

(651) 784-1250
(Registrant’s telephone number)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes   x

No   o

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class

 

Outstanding as of July 13, 2004

Common Stock, $0.02 par value

 

3,581,992

This document consists of 20 pages



PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION
AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS (Unaudited)



 

 

May 31,
2004

 

August 31,
2003

 

 

 



 



 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

96,630

 

$

283,326

 

Investments, available-for-sale

 

 

615,734

 

 

1,643,939

 

Receivables:

 

 

 

 

 

 

 

Trade excluding corporate joint ventures, less allowance for doubtful accounts of $11,563

 

 

1,546,816

 

 

1,278,173

 

Trade corporate joint ventures

 

 

712,530

 

 

292,938

 

Technical and other services, corporate joint ventures

 

 

841,550

 

 

765,679

 

Income taxes

 

 

642,969

 

 

531,088

 

Inventories

 

 

882,675

 

 

971,499

 

Prepaid expenses

 

 

179,985

 

 

125,542

 

Deferred income taxes

 

 

12,000

 

 

12,000

 

 

 



 



 

Total current assets

 

 

5,530,889

 

 

5,904,184

 

PROPERTY AND EQUIPMENT, net

 

 

622,103

 

 

526,738

 

OTHER ASSETS:

 

 

 

 

 

 

 

Investments in corporate joint ventures:

 

 

 

 

 

 

 

Industrial chemical

 

 

7,089,768

 

 

5,920,644

 

Industrial non-chemical

 

 

290,786

 

 

232,277

 

Deferred income taxes

 

 

343,000

 

 

343,000

 

Notes receivable and foreign deposit

 

 

1,356,408

 

 

1,177,847

 

Note from employee

 

 

105,049

 

 

126,043

 

Industrial patents, net

 

 

602,339

 

 

317,166

 

Other

 

 

70,268

 

 

198,777

 

 

 



 



 

 

 

 

9,857,618

 

 

8,315,754

 

 

 



 



 

 

 

$

16,010,610

 

$

14,746,676

 

 

 



 



 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Accounts payable

 

$

459,429

 

$

538,520

 

Accrued liabilities:

 

 

 

 

 

 

 

Payroll and related benefits

 

 

418,767

 

 

165,326

 

Other

 

 

438,924

 

 

440,155

 

 

 



 



 

Total current liabilities

 

 

1,317,120

 

 

1,144,001

 

DEFERRED GROSS PROFIT

 

 

25,000

 

 

25,000

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

 

 

Preferred stock, no par value, authorized 10,000 shares, none issued

 

 

—  

 

 

—  

 

Common stock, $0.02 par value per share; authorized 10,000,000 shares; issued and outstanding 3,581,992 and 3,626,192, respectively

 

 

71,640

 

 

72,524

 

Additional paid-in capital

 

 

4,105,584

 

 

4,191,964

 

Retained earnings

 

 

10,164,648

 

 

9,493,742

 

Accumulated other comprehensive income (loss)

 

 

326,618

 

 

(180,555

)

 

 



 



 

Total stockholders’ equity

 

 

14,668,490

 

 

13,577,675

 

 

 



 



 

 

 

$

16,010,610

 

$

14,746,676

 

 

 



 



 

See notes to consolidated financial statements.

2


NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF INCOME (Unaudited)



 

 

Three Months Ended

 

Nine Months Ended

 

 

 


 


 

 

 

May 31,
2004

 

May 31,
2003

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 



 



 

NORTH AMERICAN OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

3,101,925

 

$

2,189,926

 

$

8,184,330

 

 

6,172,113

 

Cost of goods sold

 

 

1,461,523

 

 

1,084,671

 

 

3,983,755

 

 

2,959,687

 

 

 



 



 



 



 

Gross profit

 

 

1,640,402

 

 

1,105,255

 

 

4,200,575

 

 

3,212,426

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 

561,967

 

 

435,024

 

 

1,574,003

 

 

1,260,552

 

General and administrative

 

 

656,428

 

 

529,798

 

 

1,845,241

 

 

1,603,898

 

Lab and technical support

 

 

157,512

 

 

225,111

 

 

487,771

 

 

629,641

 

 

 



 



 



 



 

 

 

 

1,375,907

 

 

1,189,933

 

 

3,907,015

 

 

3,494,091

 

 

 



 



 



 



 

NORTH AMERICAN OPERATING INCOME (LOSS)

 

 

264,495

 

 

(84,678

)

 

293,560

 

 

(281,665

)

CORPORATE JOINT VENTURES AND EUROPEAN HOLDING COMPANY:

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity in income of industrial chemical corporate joint ventures and European holding company

 

 

354,712

 

 

127,747

 

 

859,620

 

 

865,159

 

Equity in income (loss of industrial non-chemical) corporate joint ventures

 

 

—  

 

 

6,517

 

 

1,334

 

 

(43,832

)

Equity in loss of business consulting corporate joint ventures

 

 

—  

 

 

28,750

 

 

(6,250

)

 

(18,750

)

Fees for technical support and other services provided to all corporate joint ventures

 

 

807,016

 

 

679,121

 

 

2,402,159

 

 

1,982,646

 

Expenses incurred in support of all corporate joint ventures

 

 

(931,631

)

 

(876,309

)

 

(2,517,308

)

 

(1,985,590

)

 

 



 



 



 



 

INCOME (LOSS) FROM ALL CORPORATE JOINT VENTURES AND EUROPEAN HOLDING COMPANY

 

 

230,097

 

 

(34,174

)

 

739,555

 

 

799,633

 

INTEREST INCOME

 

 

18,123

 

 

16,146

 

 

50,880

 

 

87,059

 

 

 



 



 



 



 

INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT)

 

 

512,715

 

 

(102,706

)

 

1,083,995

 

 

605,027

 

INCOME TAX EXPENSE (BENEFIT)

 

 

1,000

 

 

(82,000

)

 

117,000

 

 

(17,000

)

 

 



 



 



 



 

NET INCOME (LOSS)

 

$

511,715

 

$

(20,706

)

$

966,995

 

$

622,027

 

 

 



 



 



 



 

NET INCOME (LOSS) PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.14

 

$

(0.01

)

$

.27

 

$

.17

 

 

 



 



 



 



 

Diluted

 

$

.14

 

$

(0.01

)

$

.27

 

$

.17

 

 

 



 



 



 



 

WEIGHTED AVERAGE COMMON SHARES

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSUMED OUTSTANDING:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

3,610,157

 

 

3,629,863

 

 

3,610,949

 

 

3,634,756

 

 

 



 



 



 



 

Diluted

 

 

3,618,562

 

 

3,635,179

 

 

3,613,751

 

 

3,636,528

 

 

 



 



 



 



 

DIVIDENDS PAID PER COMMON SHARE:

 

$

.00

 

$

.00

 

$

.05

 

$

.085

 

 

 



 



 



 



 

See notes to consolidated financial statements.

3


NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION
AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
NINE MONTHS ENDED MAY 31, 2004 AND 2003



 

 

2004

 

2003

 

 

 



 



 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

Net income

 

$

966,995

 

$

622,027

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

Depreciation expense

 

 

118,044

 

 

141,354

 

Amortization expense

 

 

16,460

 

 

5,653

 

Equity in (income) loss from corporate joint ventures:

 

 

 

 

 

 

 

Industrial chemical

 

 

(859,620

)

 

(865,159

)

Industrial non-chemical

 

 

(1,334

)

 

43,832

 

Business consulting

 

 

6,250

 

 

18,750

 

Dividends received from corporate joint ventures

 

 

667,247

 

 

490,309

 

Gain on sale of equipment

 

 

(3,100

)

 

(3,605

)

Change in current assets and liabilities:

 

 

 

 

 

 

 

Receivables:

 

 

 

 

 

 

 

Trade excluding corporate joint ventures

 

 

(268,643

)

 

(239,955

)

Trade corporate joint ventures

 

 

(419,592

)

 

(96,361

)

Technical and other services receivables, corporate joint ventures

 

 

(75,871

)

 

1,605

 

Income taxes

 

 

(111,881

)

 

(258,590 

)

Inventories

 

 

88,824

 

 

757

 

Prepaid expenses and other

 

 

(54,443

)

 

(78,433

 

Notes receivable and foreign deposits

 

 

(178,561

)

 

(839,430

)

Employee note receivable

 

 

20,994

 

 

(65,405

)

Accounts payable

 

 

(79,091

)

 

(19,183

)

Accrued liabilities

 

 

252,210

 

 

(1,235

)

 

 



 



 

Total adjustments

 

 

(882,107

)

 

(1,765,096

)

 

 



 



 

Net cash provided by (used in) operating activities

 

 

84,888

 

 

(1,143,069

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

Sale of investments available-for-sale

 

 

1,028,205

 

 

1,822,239

 

Proceeds from the sale of property and equipment

 

 

9,550

 

 

3,605

 

Investment in joint ventures:

 

 

 

 

 

 

 

Industrial chemical

 

 

(465,000

)

 

(156,867

)

Industrial non-chemical

 

 

(61,750

)

 

(63,486

)

Business consulting

 

 

(6,250

)

 

(18,750

)

Additions to property and equipment

 

 

(219,864

)

 

(219,991

)

Partial return of original investment in European holding company

 

 

—  

 

 

30,812

 

Decrease in other assets

 

 

128,509

 

 

59,043

 

Additions to industrial patents

 

 

(301,633

)

 

(79,073

)

 

 



 



 

Net cash provided by investing activities

 

 

111,767

 

 

1,377,532

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

Dividend paid to shareholders

 

 

(181,666

)

 

(309,204

)

Repurchase of common stock

 

 

(201,685

)

 

(61,044

)

 

 



 



 

Net cash used in financing activities

 

 

(383,351

)

 

(370,248

)

 

 



 



 

NET DECREASE IN CASH AND CASH EQUIVALENTS

 

 

(186,696

)

 

(135,785

)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

 

 

283,326

 

 

230,274

 

 

 



 



 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

 

$

96,630

 

$

94,489

 

 

 



 



 

See notes to consolidated financial statements.

4


NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION
AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)



1.

INTERIM FINANCIAL INFORMATION

 

 

 

In the opinion of management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, which are of a normal recurring nature, to present fairly the consolidated financial position of Northern Technologies International Corporation and Subsidiary (the Company) as of May 31, 2004 and May 31, 2003 and the results of their operations for the three and nine months ended May 31, 2004 and May 31, 2003, and their cash flows for the nine months ended May 31, 2004 and May 31, 2003, in conformity with accounting principles generally accepted in the United States of America.

 

 

 

These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes as of and for the year ended August 31, 2003 contained in the Company’s filing on Form 10-KSB dated December 11, 2003 and with Management’s Discussion and Analysis of Financial Condition and Results of Operations appearing on pages 9 through 14 of this quarterly report.

 

 

 

Certain fiscal year 2003 amounts have been reclassified to conform to fiscal year 2004 presentations.  These reclassifications had no effect on stockholders’ equity, sales, or net income as previously reported.

 

 

2.

STOCK-BASED COMPENSATION

 

 

 

In accordance with Accounting Principles Board (APB) Opinion No. 25 and related interpretations, the Company uses the intrinsic value-based method for measuring stock-based compensation cost which measures compensation cost as the excess, if any, of quoted market price of the Company’s common stock at the grant date over the amount the employee must pay for the stock. The Company’s general policy is to grant stock options at fair value at the date of grant. Options and warrants issued to non-employees are recorded at fair value, as required by Statement of Financial Accounting Standards (SFAS) No. 123, “Accounting for Stock-Based Compensation”, using the Black Scholes pricing method.

5


 

Compensation cost has been recognized based on the fair values of options at the grant dates consistent with the provisions of SFAS No. 123, the Company’s net income (loss) and basic and diluted net income (loss) per common share would have been changed to the following pro forma amounts:


 

 

Three Months Ended

 

Nine Months Ended

 

 

 


 


 

 

 

May 31,
2004

 

May 31,
2003

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 



 



 

Net Income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

 

$

511,715

 

$

(20,706

)

$

966,995

 

$

622,027

 

Pro forma

 

$

511,715

 

$

(20,706

)

 

925,765

 

 

580,434

 

Basic net income(loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

 

$

0.14

 

$

(0.01

)

$

0.27

 

$

0.17

 

Pro forma

 

$

0.14

 

$

(0.01

)

$

0.26

 

$

0.16

 

Diluted net income(loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

 

$

0.14

 

$

(0.01

)

$

0.27

 

$

0.17

 

Pro forma

 

$

0.14

 

$

(0.01

)

$

0.26

 

$

0.16

 

Stock-based compensation, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

 

$

0

 

$

0

 

$

0

 

$

0

 

Pro forma

 

$

0

 

$

0

 

$

41,230

 

$

41,593

 


 

As noted above, accounting principles require the Company to show, on a pro forma basis, the Company’s net income if it recorded an expense for stock options at the time of grant.  Other than disclosure in this footnote, the Company does not use these pro forma results for any purpose.

 

 

 

The fair value of each option grant is estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions and results for the grants:


 

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 

Dividend yield

 

 

2.0

%

 

2.0

%

Expected volatility

 

 

42.7

%

 

44.1

%

Expected life of option

 

 

5 years

 

 

5 years

 

Average risk-free interest rate

 

 

3.63

%

 

3.04

%


3.

INVENTORIES

 

 

 

Inventories consist of the following:


 

 

May 31,
2004

 

August 31,
2003

 

 

 



 



 

Production materials

 

$

274,161

 

$

187,828

 

Finished goods

 

 

608,514

 

 

783,671

 

 

 



 



 

 

 

$

882,675

 

$

971,499

 

 

 



 



 


4.

PROPERTY AND EQUIPMENT

 

 

 

Property and equipment consist of the following:


 

 

May 31,
2004

 

August 31,
2003

 

 

 



 



 

Land

 

$

29,097

 

$

29,097

 

Buildings and improvements

 

 

744,678

 

 

639,531

 

Machinery and equipment

 

 

933,160

 

 

831,347

 

 

 



 



 

 

 

 

1,706,935

 

 

1,499,975

 

Less accumulated depreciation

 

 

1,084,832

 

 

973,237

 

 

 



 



 

 

 

$

622,103

 

$

526,738

 

 

 



 



 

6


 

5.

NOTES RECEIVABLE AND FOREIGN DEPOSITS

 

 

 

Notes receivable and foreign deposits consist of the following:


 

 

May 31,
2004

 

August 31,
2003

 

 

 



 



 

Notes receivable from North American operations

 

$

530,000

 

$

500,000

 

Notes receivable from industrial chemical corporate joint venture partners

 

 

380,939

 

 

232,378

 

Foreign deposits

 

 

445,469

 

 

445,469

 

 

 



 



 

 

 

$

1,356,408

 

$

1,177,847

 

 

 



 



 


6.

INVESTMENTS IN CORPORATE JOINT VENTURES

 

Composite financial information from the unaudited financial statements of the Company’s corporate joint ventures carried on the equity basis is summarized as follows:


 

 

May 31

 

 

 


 

 

 

2004

 

2003

 

 

 



 



 

Current assets

 

$

22,273,625

 

$

19,287,454

 

Total assets

 

 

27,317,093

 

 

24,071,516

 

Current liabilities

 

 

11,421,157

 

 

7,045,429

 

Total liabilities

 

 

12,558,746

 

 

10,385,394

 

Corporate joint ventures’ equity

 

 

14,996,978

 

 

13,841,861

 

Northern Technologies International Corporation’s share of corporate joint ventures’ equity

 

 

7,380,554

 

 

6,152,921

 


 

 

Nine Months Ended

 

 

 


 

 

 

May 31,
2004

 

August 31,
2003

 

 

 


 


 

Sales

 

$

35,092,876

 

$

27,069,668

 

Gross profit

 

 

16,601,231

 

 

13,038,463

 

Net income from continuing operations

 

 

1,674,717

 

 

1,422,457

 

Net income

 

 

1,674,717

 

 

1,422,457

 

Northern Technologies International Corporation’s share of equity in income of Corporate Joint Ventures

 

 

854,704

 

 

802,577

 


 

During 2004, the Company has invested in a variety of new and existing Corporate Joint Ventures as follows:

 

 

 

In September 2003 the Company invested an additional $440,000 in React-NTI LLC, in connection with React-NTI LLC’s acquisition of React Inc.  React-NTI LLC is an industrial chemical joint venture formed in fiscal 2003 in which the Company now has a 75% ownership interest and has made capital contributions of $750,000.  Under the terms of the agreement related to React-NTI LLC, there are certain matters requiring unanimous approval of the Company and the minority shareholder.  These rights represent substantive participating rights of the minority shareholder as defined in Emerging Issues Task Force (EITF) No. 96-16, Investor’s Accounting for an Investee When the Investor has a Majority of the Voting Interest but the Minority Shareholder or Shareholders Have Certain Approval or Veto Rights.  Accordingly, the Company does not control

7


 

React-TI LLC and will account for its investment under the equity method rather than by consolidation.  The Company believes that React-NTI LLC has sufficient equity to finance its activities without additional subordinated financial support from other parties, and accordingly does not expect to make additional capital contributions or provide financing to React-NTI, LLC.  Any future changes to the LLC agreement or the financial arrangements surrounding this investment could result in consolidation of React-NTI LLC in the future.  In connection with its acquisition of React, Inc., React-NTI LLC has allocated a portion of the purchase price to intangible assets.  This allocation is based on a preliminary estimate of the value of identifiable intangible assets and is subject to adjustment based upon further analysis and appraisal which could impact the equity in income or loss recorded by the Company related to amortization of intangible assets deemed to have finite lives.

 

 

 

In October 2003 the Company invested $6,250 in an existing business consulting corporate joint venture in the United States.  The Company has obtained a 25% ownership interest in this company to utilize various government and military associations.  As the company has no assets its investment value is $0.

 

 

 

In January 2004 the Company invested $20,000 in a new industrial chemical corporate joint venture to develop new operations in Lebanon.  The Company has a 50% ownership interest in the new entity.  The new entity had no operations prior to the Company’s investment.  It is anticipated that this is the first installment toward completed capitalization of an estimated $75,000.

 

 

 

During the second quarter of 2004, through a series of transactions utilizing Northern Instruments Corporation LLC as an investment vehicle, the Company invested $61,750 to increase its ownership interests in a German GmbH from 30% to 40%.

 

 

7.

STOCKHOLDERS’ EQUITY

 

 

 

During the nine months ended May 31, 2004, the Company repurchased and retired 44,200 shares of common stock for between $4.45 and $4.70 per share.

 

 

8.

SUPPLEMENTAL CASH FLOW INFORMATION

 

 

 

During the nine months ended May 31, 2004, the Company declared a cash dividend of $0.05 per share that was paid on December 17, 2003 to shareholders of record on December 3, 2003.

 

 

9.

TOTAL COMPREHENSIVE INCOME

 

 

 

The Company’s total comprehensive income was as follows:


 

 

Three Months Ended

 

Nine Months Ended

 

 

 


 


 

 

 

May 31,
2004

 

May 31,
2003

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 



 



 

Net income (loss)

 

$

511,715

 

$

(20,706

)

$

966,995

 

$

622,027

 

Other comprehensive (loss) income –foreign currency translation adjustment

 

 

(86,172

)

 

185,179

 

 

507,173

 

 

359,272

 

 

 



 



 



 



 

Total comprehensive income

 

$

425,543

 

$

164,473

 

$

1,474,168

 

$

981,229

 

 

 



 



 



 



 

8


10.

NET INCOME PER SHARE


 

Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding.  Diluted net income per share assumes the exercise of stock options using the treasury stock method, if dilutive.

 

 

 

Options to purchase 70,655 shares of common stock with a weighted average exercise price of $6.06 were outstanding at May 31, 2004, but were excluded from the computation of common share equivalents for the three and nine months ended May 31, 2004, because their exercise prices were greater than the average market price of the common shares.

 

 

 

The following table summarizes information about stock options outstanding at May 31, 2004:


 

 

Options Outstanding

 

Options Exercisable

 

 

 


 


 

Range of
Exercise
  Prices

 

 

Number
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Number
Exercisable

 

 

Exercise
Price

 


 



 



 



 



 

$3.34 - $7.00

 

 

124,665

 

$

5.27

 

 

74,662

 

$

5.77

 


11.

SEGMENT INFORMATION

 

 

 

The Company is engaged in the development, manufacturing, and marketing of proprietary materials science based industrial packaging products.  Further disclosure regarding the two businesses is not presented, as management uses the consolidated information to allocate resources and evaluate performance.

 

 

 

Sales by geographic location as a percentage of total sales were as follows:


 

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 

U.S.A. to unaffiliated customers Outside the U.S.A. to:

 

 

69

%

 

70

%

Corporate Joint Ventures

 

 

9

 

 

10

 

Unaffiliated customers

 

 

22

 

 

20

 

 

 



 



 

 

 

 

100

%

 

100

%

 

 



 



 


 

One customer accounted for approximately 18% and 13% of net sales for the fiscal periods ended May 31, 2004 and 2003, respectively.

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

Critical Accounting Policies

Sales Originating in North America – Northern Technologies International Corporation and Subsidiary (the Company) considers sales originating in North America to be all sales shipped/invoiced from the Company’s facilities located in Minnesota and Ohio.  There are no sales from the Corporate Joint Ventures included in the amount as the Company’s investments in Corporate Joint Ventures are accounted for using the equity method.

9


Cash Equivalents - The Company considers investments with an original maturity of three months or less to be cash equivalents.

Investments Available for Sale - The Company accounts for securities available for sale in accordance with Statement of Financial Accounting Standards No. 115, Accounting for Certain Investments in Debt and Equity Securities (SFAS No. 115).  SFAS No. 115 requires that available-for-sale securities be carried at fair value, with unrealized gains and losses reported as other comprehensive income within stockholders’ equity, net of applicable income taxes.  Realized gains and losses and declines in value deemed to be other-than-temporary on available-for-sale securities are included in other income.  Fair value of the securities is based upon the quoted market price on the last business day of the quarter or fiscal year.  The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis.  At May 31, 2004, the Company’s available-for-sale securities are temporarily in various money market accounts with a fair value totaling $615,734.

Inventories - Inventories are recorded at the lower of cost (first-in, first-out basis) or market.

Property and Depreciation - Property and equipment are stated at cost.  Depreciation is computed using the straight-line method based on the estimated service lives of the various assets as follows:

Buildings and improvements

5-20 years

Machinery and equipment

3-10 years

Investments in Corporate Joint Ventures - Investments in Corporate Joint Ventures are accounted for using the equity method.  Intercompany profits on inventories held by the Corporate Joint Ventures that were purchased from the Company have been eliminated based on the Company’s ownership percentage in each corporate joint venture.

Recoverability of Long-Lived Assets - The Company reviews its long-lived assets whenever events or changes in circumstances indicate the carrying amount of the assets may not be recoverable.  The Company determines potential impairment by comparing the carrying value of the assets with expected net cash flows expected to be provided by operating activities of the business or related products.  Should the sum of the expected undiscounted future net cash flows be less than the carrying value, the Company would determine whether an impairment loss should be recognized.  An impairment loss would be measured by comparing the amount by which the carrying value exceeds the fair value of the asset.  As of May 31, 2004, the Company did not consider any of its assets impaired.

Income Taxes - The Company utilizes the liability method of accounting for income taxes as set forth in Statement of Financial Accounting Standards (SFAS) No. 109, Accounting for Income Taxes.  SFAS No. 109 requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

10


Foreign Currency Translation (Accumulated Other Comprehensive Income (Loss)) - The functional currency of each international corporate joint venture is the applicable local currency.  The translation of the applicable foreign currencies into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using an average monthly exchange rate.  Translation gains or losses are reported as an element of accumulated other comprehensive income (loss).

Revenue Recognition - In recognizing revenue, the Company applies the provisions of the Securities and Exchange Commission Staff Accounting Bulletin 101, Revenue Recognition.  The Company recognizes revenue from the sale of its products when persuasive evidence of an arrangement exists, the product has been delivered, the fee is fixed and determinable and collection of the resulting receivable is reasonably assured.  A portion of the gross profit on products shipped to the Company’s Corporate Joint Ventures is deferred until such products are sold by the Corporate Joint Ventures.

Shipping and Handling - The Company records all amounts billed to customers in a sales transaction related to shipping and handling as sales.  The Company records costs related to shipping and handling in cost of goods sold. 

Use of Estimates - The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

RESULTS OF OPERATIONS

General - The Company conducts all foreign transactions based on the U.S. dollar, except for its investments in various foreign corporate joint ventures.  The exchange rate differential relating to investments in foreign corporate joint ventures is accounted for under the requirements of SFAS No. 52, Foreign Currency Translation.

NORTH AMERICAN OPERATIONS

Sales - Sales increased by $911,999 or 41.65% during the third quarter of 2004 from those of the third quarter of 2003.  Net sales increased by $2,012,217 or 32.6% during the nine months ended May 31, 2004 compared to the nine months ended May 31, 2003.  These changes in sales are due to an increase in demand for materials science based industrial packaging products from existing and new customers. 

Cost of Sales - Cost of goods sold as a percentage of net sales were 47.1% and 49.5% for the third quarter of 2004 and 2003, respectively.  The cost of goods sold percentage of net sales was 48.7% and 48.0% for the nine months ended May 31, 2004 and May 31, 2003, respectively.  Variations are due primarily to the mix of product sales and changes in the price of resin.

Operating Expenses - As a percentage of net sales, total operating expenses were 44.4% in the third quarter of fiscal 2004 and 54.3% in the third quarter of fiscal 2003.  Operating expenses were 47.7% and 56.6% of net sales for the nine months ended May 31, 2004 and for the nine months ended May 31, 2003.

11


Operating expense classification percentages of net sales were as follows:

 

 

Three Months Ended

 

Nine Months Ended

 

 

 


 


 

 

 

May 31,
2004

 

May 31,
2003

 

May 31,
2004

 

May 31,
2003

 

 

 



 



 



 



 

Selling

 

 

18

%

 

20

%

 

19

%

 

20

%

General and administrative

 

 

21

 

 

24

 

 

23

 

 

26

 

Research, engineering, and technical support

 

 

5

 

 

10

 

 

6

 

 

10

 

Selling Expenses.  The Company’s selling expenses increased by $126,943 or 29.2% to $561,967 during the third quarter of fiscal 2004 as compared to $435,024 during the same period in fiscal 2003.  The increase in selling expenses during the third quarter of fiscal 2004 was primarily related to the hiring of additional salespeople and associated commission and travel related expenses.  As a percentage of sales, selling expense decreased to 18.1% in the third quarter of fiscal 2004 from 19.9% in the third quarter of fiscal 2003.   Selling expenses increased by $313,451 or 24.9% to $1,574,003 during the nine months ended May 31, 2004 compared to the nine months ended May 31, 2003 due to the same reasons.  During the nine months ended May 31, 2004 selling expense decreased to 19.2% of sales from 20.4% during the nine months ended May 31, 2003. 

General and Administrative Expenses.  The Company’s general and administrative expenses increased by $126,630 or 23.9% to $656,428 during the third quarter of fiscal 2004 as compared to $529,798 during the same period in fiscal 2003.  The increase is attributable to increases in insurance, outside auditing, travel and accrued management bonus offset by decreases in legal expenses and rent.  As a percentage of sales, general and administrative expenses decreased to 21.2% in the third quarter of fiscal 2004 from 24.2% in the third quarter of fiscal 2003.   General and administrative expenses increased by $241,343 or 15.1% to $1,845,241 during the nine months ended May 31, 2004 compared to the nine months ended May 31, 2003 due to the same reasons. During the nine months ended May 31, 2004 general and administrative expenses decreased to 22.5% of sales from 26.0% during the nine months ended May 31, 2003. 

Lab and Technical Support Expenses.  The Company’s lab and technical support expenses decreased by $67,599 or 30.0% to $157,512 during the third quarter of fiscal 2004 as compared to $225,111 during the same period in fiscal 2003.  The decrease in lab and technical support expenses during the third quarter of fiscal 2004 was primarily related to decreases in salary expense and technical consulting expense, due to a number of employees being realigned from lab and technical support to corporate joint venture support.  As a percentage of sales, lab and technical support expenses decreased to 5.1% in the third quarter of fiscal 2004 from 10.3% in the third quarter of fiscal 2003.  Lab and technical support expenses decreased by $141,870 or 22.5% to $487,771 during the nine months ended May 31, 2004 compared to the nine months ended May 31, 2003 due to the same reasons. During the nine months ended May 31, 2004 lab and technical support expenses decreased to 6.0% of sales from 10.2% during the nine months ended May 31, 2003. 

CORPORATE JOINT VENTURES AND EUROPEAN HOLDING COMPANY

Corporate Joint Ventures and European Holding Company - Net earnings from corporate joint ventures and European holding company were $739,555 for the nine months ended May 31, 2004, respectively, compared to $799,633 for the nine months ended May 31, 2003.  This decrease is due to significant increases in expenses incurred in support of corporate joint ventures being offset by significant increases in the fees for technical support and other services.  Specific increases in fees for technical services include the salaries of rededicated employees to Corporate Joint Venture technical support and new product development, increases in legal and external consulting expense.

12


The Company sponsors a worldwide Corporate Joint Venture conference approximately every three years in which all of its Corporate Joint Ventures are invited to participate.  The Company defers a portion of its royalty income received from its Corporate Joint Ventures in each accounting period leading up to the next conference, reflecting that the Company has not fully earned the royalty payments received during that period. The next Joint Venture conference is scheduled to be held in September of 2005, there is $316,000 of deferred royalty income recorded within other accrued liabilities at May 31, 2004, related to this conference.  The deferred income is expected to be recognized in income in 2005 as expenses are incurred when the conference is held.  The costs associated with these joint venture conferences are recognized as incurred, generally in the period in which the conference is held.

The Company incurred direct expenses related to Corporate Joint Ventures and the European holding company of $931,631 and $2,517,308 in three and nine months ended May 31, 2004 and $876,309 and $1,985,590 in the three and nine months ended May 31, 2003. These expenses include: consulting, travel, technical and marketing services to existing joint ventures, legal fees regarding the establishment of new joint ventures, registration and promotion and legal defense of worldwide trademarks and legal fees incurred in the filing of patent applications for new technologies to which the Company acquired certain rights.  Increases related to the three and nine months ended May 31, 2004 as compared to three and nine months ended May 31, 2003 are attributable to increase in management and coordinator salaries, legal expense and external consulting services.

INCOME TAX

Income Taxes - Income tax expense for the three and nine months ended May 31, 2004 and May 31, 2003 was calculated based on management’s estimate of the Company’s annual effective income tax rate.  The Company’s annual effective income tax rate for fiscal 2004 is lower than the statutory rate primarily due to the Company’s equity in income of corporate joint ventures being recognized based on after-tax earnings of these entities.  To the extent joint ventures’ undistributed earnings are distributed to the Company, it is not expected to result in any material additional income tax liability after the application of foreign tax credits.

LIQUIDITY AND CAPITAL RESOURCES

At May 31, 2004, the Company’s working capital was $4,213,769, including $96,630 in cash and cash equivalents and $615,734 in investments available for sale, compared to a working capital of $4,760,183, including $283,326 in cash and cash equivalents and $1,643,939 in investments available for sale at August 31, 2003.

Cash flows provided by (used in) operations for the nine months ended May 31, 2004 and May 31, 2003 were $84,888 and ($1,143,069), respectively.  The net cash provided by operations for the nine months ended May 31, 2004 resulted principally from net income being partially offset by the noncash equity income of industrial chemical joint ventures, and uses of cash for increases in operating assets more than offsetting net increases in operating liabilities.  During the nine months ended February 2003, the Company made a $445,469 deposit relating to a legal case involving potential trademark infringement against a competitor in Europe.  The Company expects that the amount will be fully recoverable at the conclusion of the prosecution of the competitor.  The net cash used in operations for the nine months ended May 31, 2003 resulted principally from net income and dividends received from corporate joint ventures being more than offset by the noncash equity income of industrial chemical joint ventures and uses of cash for increases in operating assets and reductions of operating liabilities. 

Net cash provided by investing activities for the nine months ended May 31, 2004 was $111,767, which resulted from the sales of investments offset by investments in corporate joint ventures and additions to

13


property and equipment and industrial patents.  Net cash provided by investing activities for the nine months ended May 31, 2003 was $1,377,532, which resulted from the sale of investments and from the partial return of the Company’s original investment in European holding company partially offset by investments in international joint ventures, additions to patents and additions to property and equipment. 

Net cash used in financing activities for the nine months ended May 31, 2004 was $383,351, which resulted primarily from the payment of dividends to shareholders and the repurchase of common stock.  Net cash used in financing activities for the nine months ended May 31, 2003 was $370,248, which resulted from the repurchase of common stock and the payment of dividends to shareholders.

The Company expects to meet future liquidity requirements by utilizing its existing cash and cash equivalents and investments available for sale combined with cash flows from future operations and distributions of earnings and technical assistance fees to the Company from the corporate joint venture investments.

The Company has no long-term debt and no material capital lease commitments as of May 31, 2004; however, the Company’s subsidiary has entered into a 15-year lease agreement for 16,994 square feet of office, manufacturing, laboratory, and warehouse space requiring monthly payments of $17,072, which are adjusted annually according to the annual consumer price index through November 2014.

The Company has no postretirement benefit plan and does not anticipate establishing any postretirement benefit program.

Inflation in the U.S. historically has had little effect on the Company.

Recently Issued Accounting Pronouncements

In January 2003, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51.  In December 2003, the FASB issued FIN 46R, Consolidation of Variable Interest Entities, a revision of FIN 46 which addresses consolidation by business enterprises where equity investors do not bear the residual economic risks and rewards.  These entities have been commonly referred to as “special purpose entities.”  The provisions of FIN 46R are effective for interests in variable interest entities (VIE) as of the first interim, or annual, period ending after December 15, 2004 except for VIEs considered special-purpose entities.  The Company is in the process of evaluating the impact this will have on the consolidated financial statements of the Company. 

In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.  This Statement requires that certain financial instruments previously accounted for as equity under previous guidance be classified as liabilities in statements of financial position.  SFAS No. 150 became effective for all financial instruments entered into or modified after May 31, 2003 and otherwise effective at the beginning of the first interim period beginning after June 15, 2003.  The adoption of SFAS No. 150 did not have an impact on the Company’s results of operations or financial position.

ITEM 3 – CONTROLS AND PROCEDURES

Disclosure of the Control Environment

As of May 31, 2004, the end of the period covered by this report, the Company carried out an evaluation under the supervision of, and with participation from, its Chairman of the Board & Chief Executive Officer and Chief Financial Officer, of the Company’s disclosure controls and procedures (as defined in Rules 13a-

14


15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the Exchange Act).  Based upon that evaluation the Company, as well as its Chairman of the Board & Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures need improvement to be considered effective.  We continue to evaluate methods to improve our internal controls and procedures and the Company intends to evaluate and fix all weaknesses in internal controls as required by the rules promulgated under the Exchange Act and the Sarbanes-Oxley Act of 2002. We do not believe that these disclosure and internal control deficiencies resulted in any material misstatements in our consolidated financial statements contained in this Form 10-QSB.

PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS:

None

 

 

ITEM 2 - CHANGES IN SECURITIES:

None

 

 

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES:

None

 

 

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS:

None

 

 

ITEM 5 - OTHER INFORMATION:

None

 

 

ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K

 


 

(a)

Exhibits

 

 

 

 

None; however the written statements of our applicable officers, as required pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, accompanied the filing of this report as correspondence to the Securities and Exchange Commission.

 

 

 

 

(b)

Reports on Form 8-K

 

 

 

 

The Company filed an 8-K on June 8, 2004; the filing disclosed changes in registrant’s certifying accountant from Deloitte & Touche LLP to Virchow, Krause & Company, LLP.

15


SIGNATURE PAGE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION

 

 

 

 

Message

 

 


 

Date:  July 13, 2004

Matthew C. Wolsfeld, CPA
Chief Financial Officer

 

 

 

 

 

(Mr. Wolsfeld is the Principal Financial and Accounting Officer and has been duly authorized to sign on behalf of the registrant.)

 

16


CERTIFICATION PURSUANT TO SECTION 302(A) OF THE SARBANES-OXLEY ACT OF 2002

I, Philip M. Lynch, certify that:

 

 

 

1.

I have reviewed this quarterly report on Form 10-QSB of Northern Technologies International Corporation;

 

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

 

 

 

4.

The small business issuer’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

 

 

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(c)

Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s current reported quarter that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting; and

 

 

 

5.

The small business issuer’s other certifying officers and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent function):

 

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal controls over financial reporting.


 

Message

 

Date:  July 13, 2004


 

 

Philip M. Lynch
Chairman of the Board of Directors &
Chief Executive Officer

 

17


CERTIFICATION PURSUANT TO SECTION 302(A) OF THE SARBANES-OXLEY ACT OF 2002

1.

I have reviewed this quarterly report on Form 10-QSB of Northern Technologies International Corporation;

 

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

 

 

 

4.

The small business issuer’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

 

 

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(c)

Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s current reported quarter that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting; and

 

 

 

5.

The small business issuer’s other certifying officers and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent function):

 

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal controls over financial reporting.


 

Message

 

 


 

Date:  July 13, 2004

Matthew C. Wolsfeld, CPA
Chief Financial Officer

 

18


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Northern Technologies International Corporation (the “Company”) on Form 10-QSB for the period ending May 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip M. Lynch, Chairman of the Board and Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Message

 

Chairman of the Board of Directors & Chief Executive Officer (principal executive officer)


 

 

Philip M. Lynch

 

 

 

 

 

Lino Lakes, Minnesota

 

 

July 13, 2004

 

 

19


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Northern Technologies International Corporation (the “Company”) on Form 10-QSB for the period ending May 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew C. Wolsfeld, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 

 

Chief Financial Officer (principal financial officer and principal accounting officer)

 

 

 

Message

 

 


 

 

Matthew C. Wolsfeld, CPA

 

 

 

 

 

Lino Lakes, Minnesota

 

 

July 13, 2004

 

 

20